Ephraim Heiliczer is a Senior Associate in the Intellectual Property Group at Pearl Cohen’s Tel Aviv office. Ephraim has a strong background in medical science and has been involved in numerous life science oppositions and infringement actions as well as in patent prosecution.
Ephraim has litigated cases involving drug release profiles and pharmacokinetics, drug metabolism, anti-HIV agents, CNS drugs and medical devices.
Ephraim worked extensively with some of the world’s leading scientific experts and his scientific background was paramount in developing novel arguments to rebut challenges to patentability and to overcome Patent Office objections.
Ephraim is presently a JSD candidate at Columbia Law School.
Prior to joining Pearl Cohen, Ephraim worked for several years at Liad Whatstein & Co.